This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Michio Iwahana: Innovator in Thiazolopyrimidine Derivatives
Introduction
Michio Iwahana is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of thiazolopyrimidine derivatives. His work has implications for treating various diseases related to angiogenesis.
Latest Patents
Iwahana holds a patent for thiazolopyrimidine derivatives, which are characterized by a carboxamide residue substituted with R.sup.4 and R.sup.5. These derivatives and their salts exhibit antiangiogenic activity, making them useful in the treatment of diseases such as diabetic retinopathy, chronic inflammation conditions, and malignant solid tumors. His patent is a testament to his innovative approach in addressing critical health issues.
Career Highlights
Iwahana is associated with Daiichi Pharmaceutical Co., Ltd., where he has made significant strides in pharmaceutical research and development. His work has not only advanced scientific understanding but also contributed to potential therapeutic solutions for patients.
Collaborations
Some of his notable coworkers include Hiroo Matsumoto and Haruko Chatani. Their collaborative efforts have further enhanced the research and development initiatives at Daiichi Pharmaceutical Co., Ltd.
Conclusion
Michio Iwahana's contributions to the field of pharmaceuticals, particularly through his patent on thiazolopyrimidine derivatives, highlight his role as an innovator. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile